| Basic data
|
| (21) | Request Number: | S20240040A (Supplementary Protection Certificate granted) |
| (22) | Request Date: | 13.12.2024 |
| (43) | Request Publication Date: | 03.01.2025 |
| |
| (71) | Applicant(s): | | 1. | Merck Sharp & Dohme LLC, 126 East Lincoln Avenue, P.O.Box 2000, Rahway, NJ 07065, US |
|
| (74) | Representative: | ZMP IP d.o.o.,
Baruna Trenka 7, 10000 Zagreb, HR
|
| |
| (68) | Basic Patent Number: | P20120129 |
| (21) | Application Number | P20120129A |
| (22) | Filing Date | 07.02.2012 |
| (54) | Title of Invention: | HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS |
| |
| (95) | Product Name: | VIBEGRON ILI NJEGOVA FARMACEUTSKI PRIHVATLJIVA SOL |
| |
| (92)(93) | Number and Date of First Marketing Authorisation: | |
| |
| (11) | SPC Number: | S20240040 |
| | Date of Grant: | 30.04.2026 |
| | Publication Date: | 08.05.2026 |
| (94) | Validity Period: | 03.04.2029 - 02.04.2034 |
| |
| |